Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antje Augstein

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
International Journal of Molecular Sciences|October 14, 2022
Empagliflozin Preserves Skeletal Muscle Function in a HFpEF Rat ModelEphraim B Winzer, Antje Schauer, Erik Langner, et al.
Cells|March 27, 2024
Leucine Supplementation Prevents the Development of Skeletal Muscle Dysfunction in a Rat Model of HFpEFPaula Ketilly Nascimento Alves, Antje Schauer, Antje Augstein, et al.
ESC Heart Failure|July 26, 2020
ZSF1 rat as animal model for HFpEF: Development of reduced diastolic function and skeletal muscle dysfunctionAntje Schauer, Runa Draskowski, Anett Jannasch, et al.
Atherosclerosis|February 25, 2014
Local inhibition of hypoxia-inducible factor reduces neointima formation after arterial injury in ApoE-/- miceMarian Christoph, Karim Ibrahim, Kathleen Hesse, et al.
Cells|November 10, 2023
Leucine Supplementation Improves Diastolic Function in HFpEF by HDAC4 InhibitionPaula Ketilly Nascimento Alves, Antje Schauer, Antje Augstein, et al.
Journal of Cachexia, Sarcopenia and Muscle|June 4, 2025
MyoMed205 Counteracts Titin Hyperphosphorylation and the Expression of Contraction-Regulating Proteins in a Rat Model of HFpEFBeatrice Vahle, Antje Schauer, Antje Augstein, et al.
International Journal of Molecular Sciences|April 3, 2021
Sacubitril/Valsartan Improves Diastolic Function But Not Skeletal Muscle Function in a Rat Model of HFpEFAntje Schauer, Volker Adams, Antje Augstein, et al.
Circulation. Heart Failure|June 15, 2026
Targeting Mitochondrial Dysfunction With Elamipretide (SS-31) Improves Skeletal Muscle Performance in a HFpEF Rat ModelBeatrice Vahle, Sven Weidner, André Tomalka, et al.
Journal of Cachexia, Sarcopenia and Muscle|March 18, 2022
Targeting MuRF1 by small molecules in a HFpEF rat model improves myocardial diastolic function and skeletal muscle contractilityVolker Adams, Antje Schauer, Antje Augstein, et al.
ESC Heart Failure|December 22, 2020
Muscular changes in animal models of heart failure with preserved ejection fraction: what comes closest to the patient?Keita Goto, Antje Schauer, Antje Augstein, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|October 14, 2022
Empagliflozin Preserves Skeletal Muscle Function in a HFpEF Rat ModelEphraim B Winzer, Antje Schauer, Erik Langner, et al.
Cells|March 27, 2024
Leucine Supplementation Prevents the Development of Skeletal Muscle Dysfunction in a Rat Model of HFpEFPaula Ketilly Nascimento Alves, Antje Schauer, Antje Augstein, et al.
ESC Heart Failure|July 26, 2020
ZSF1 rat as animal model for HFpEF: Development of reduced diastolic function and skeletal muscle dysfunctionAntje Schauer, Runa Draskowski, Anett Jannasch, et al.
Atherosclerosis|February 25, 2014
Local inhibition of hypoxia-inducible factor reduces neointima formation after arterial injury in ApoE-/- miceMarian Christoph, Karim Ibrahim, Kathleen Hesse, et al.
Cells|November 10, 2023
Leucine Supplementation Improves Diastolic Function in HFpEF by HDAC4 InhibitionPaula Ketilly Nascimento Alves, Antje Schauer, Antje Augstein, et al.
Journal of Cachexia, Sarcopenia and Muscle|June 4, 2025
MyoMed205 Counteracts Titin Hyperphosphorylation and the Expression of Contraction-Regulating Proteins in a Rat Model of HFpEFBeatrice Vahle, Antje Schauer, Antje Augstein, et al.
International Journal of Molecular Sciences|April 3, 2021
Sacubitril/Valsartan Improves Diastolic Function But Not Skeletal Muscle Function in a Rat Model of HFpEFAntje Schauer, Volker Adams, Antje Augstein, et al.
Circulation. Heart Failure|June 15, 2026
Targeting Mitochondrial Dysfunction With Elamipretide (SS-31) Improves Skeletal Muscle Performance in a HFpEF Rat ModelBeatrice Vahle, Sven Weidner, André Tomalka, et al.
Journal of Cachexia, Sarcopenia and Muscle|March 18, 2022
Targeting MuRF1 by small molecules in a HFpEF rat model improves myocardial diastolic function and skeletal muscle contractilityVolker Adams, Antje Schauer, Antje Augstein, et al.
ESC Heart Failure|December 22, 2020
Muscular changes in animal models of heart failure with preserved ejection fraction: what comes closest to the patient?Keita Goto, Antje Schauer, Antje Augstein, et al.
Pageof 5